Journey Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Journey Advisory Group, LLC
- $1.25 Billion
- Q2 2025
A detailed history of Journey Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Journey Advisory Group, LLC holds 17,661 shares of BMY stock, worth $813,642. This represents 0.07% of its overall portfolio holdings.
Number of Shares
17,661
Previous 17,896
1.31%
Holding current value
$813,642
Previous $1.09 Million
25.11%
% of portfolio
0.07%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...